These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W. J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767 [Abstract] [Full Text] [Related]
3. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Arteaga CL, Osborne CK. Cancer Res; 1989 Nov 15; 49(22):6237-41. PubMed ID: 2553250 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor receptor expression and function in human breast cancer. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N. Cancer Res; 1990 Jan 01; 50(1):48-53. PubMed ID: 2152773 [Abstract] [Full Text] [Related]
5. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model. Thompson MA, Cox AJ, Whitehead RH, Jonas HA. Endocrinology; 1990 Jun 01; 126(6):3033-42. PubMed ID: 1693565 [Abstract] [Full Text] [Related]
6. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F. Mol Endocrinol; 1990 Sep 01; 4(9):1327-35. PubMed ID: 2172799 [Abstract] [Full Text] [Related]
7. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA. J Clin Invest; 1989 Sep 01; 84(3):829-39. PubMed ID: 2547840 [Abstract] [Full Text] [Related]
8. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. Bradley LM, Gierthy JF, Pentecost BT. J Steroid Biochem Mol Biol; 2008 Mar 01; 109(1-2):185-96. PubMed ID: 18337089 [Abstract] [Full Text] [Related]
9. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors. Hershkovitz E, Marbach M, Bosin E, Levy J, Roberts CT, LeRoith D, Schally AV, Sharoni Y. J Clin Endocrinol Metab; 1993 Oct 01; 77(4):963-8. PubMed ID: 8408472 [Abstract] [Full Text] [Related]
10. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK. Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252 [Abstract] [Full Text] [Related]
11. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Macaulay VM, Everard MJ, Teale JD, Trott PA, Van Wyk JJ, Smith IE, Millar JL. Cancer Res; 1990 Apr 15; 50(8):2511-7. PubMed ID: 2156621 [Abstract] [Full Text] [Related]
12. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ, Jordan VC. Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307 [Abstract] [Full Text] [Related]
13. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA. J Cell Physiol; 1993 Jun 15; 155(3):556-67. PubMed ID: 7684042 [Abstract] [Full Text] [Related]
14. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. van der Burg B, Isbrücker L, van Selm-Miltenburg AJ, de Laat SW, van Zoelen EJ. Cancer Res; 1990 Dec 15; 50(24):7770-4. PubMed ID: 2174732 [Abstract] [Full Text] [Related]
15. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8. Takigawa M, Okawa T, Pan H, Aoki C, Takahashi K, Zue J, Suzuki F, Kinoshita A. Endocrinology; 1997 Oct 15; 138(10):4390-400. PubMed ID: 9322955 [Abstract] [Full Text] [Related]
16. Regulation of breast cancer growth by insulin-like growth factors. Osborne CK, Clemmons DR, Arteaga CL. J Steroid Biochem Mol Biol; 1990 Dec 20; 37(6):805-9. PubMed ID: 2178363 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F. J Clin Invest; 1988 Jul 20; 82(1):354-9. PubMed ID: 2839551 [Abstract] [Full Text] [Related]
18. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Daly RJ, Harris WH, Wang DY, Darbre PD. Cell Growth Differ; 1991 Sep 20; 2(9):457-64. PubMed ID: 1661135 [Abstract] [Full Text] [Related]
19. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Read LD, Greene GL, Katzenellenbogen BS. Mol Endocrinol; 1989 Feb 20; 3(2):295-304. PubMed ID: 2785242 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor II mRNA expression in human breast cancer. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N. Cancer Res; 1988 Dec 01; 48(23):6691-6. PubMed ID: 3180080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]